Stay updated on Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T14:08:22.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The 403 error screen and its Home link are gone, replaced by a mostly blank study-record page with a sitewide NIH transition notice at the top.
    Difference
    2%
    Check dated 2026-10-25T13:45:04.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1. The page continues to show a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-18T14:11:15.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 on the 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-11T13:22:53.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The study page displays a 403 Forbidden message with a Home link instead of study-record content.
    Difference
    0.5%
    Check dated 2026-10-04T15:21:41.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record for NCT03734809. This indicates restricted access to the page, replacing the expected study content with an error screen.
    Difference
    18%
    Check dated 2026-09-20T20:39:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.